全文获取类型
收费全文 | 742179篇 |
免费 | 47579篇 |
国内免费 | 1546篇 |
专业分类
耳鼻咽喉 | 9352篇 |
儿科学 | 22656篇 |
妇产科学 | 17836篇 |
基础医学 | 113436篇 |
口腔科学 | 18695篇 |
临床医学 | 67705篇 |
内科学 | 141600篇 |
皮肤病学 | 15286篇 |
神经病学 | 59153篇 |
特种医学 | 28284篇 |
外国民族医学 | 76篇 |
外科学 | 112741篇 |
综合类 | 10938篇 |
现状与发展 | 1篇 |
一般理论 | 294篇 |
预防医学 | 55137篇 |
眼科学 | 17505篇 |
药学 | 55624篇 |
1篇 | |
中国医学 | 1318篇 |
肿瘤学 | 43666篇 |
出版年
2021年 | 8191篇 |
2019年 | 8276篇 |
2018年 | 10796篇 |
2017年 | 7942篇 |
2016年 | 8757篇 |
2015年 | 10049篇 |
2014年 | 14121篇 |
2013年 | 20430篇 |
2012年 | 29575篇 |
2011年 | 31675篇 |
2010年 | 18076篇 |
2009年 | 16843篇 |
2008年 | 29118篇 |
2007年 | 30852篇 |
2006年 | 30651篇 |
2005年 | 29969篇 |
2004年 | 28715篇 |
2003年 | 26812篇 |
2002年 | 26065篇 |
2001年 | 25942篇 |
2000年 | 26465篇 |
1999年 | 22496篇 |
1998年 | 8123篇 |
1997年 | 6853篇 |
1996年 | 6908篇 |
1995年 | 6320篇 |
1994年 | 5794篇 |
1993年 | 5584篇 |
1992年 | 16668篇 |
1991年 | 17213篇 |
1990年 | 17184篇 |
1989年 | 16517篇 |
1988年 | 15223篇 |
1987年 | 15018篇 |
1986年 | 14212篇 |
1985年 | 13641篇 |
1984年 | 10517篇 |
1983年 | 9013篇 |
1979年 | 9869篇 |
1978年 | 7356篇 |
1977年 | 6208篇 |
1976年 | 6010篇 |
1975年 | 6700篇 |
1974年 | 7937篇 |
1973年 | 7387篇 |
1972年 | 7129篇 |
1971年 | 6837篇 |
1970年 | 6276篇 |
1969年 | 5965篇 |
1968年 | 5629篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
102.
103.
104.
E Chankiewitz D Peschke L Herberg I Bazwinsky E Mühlbauer H-J Br?mme E Peschke 《Experimental and clinical endocrinology & diabetes》2006,114(5):262-269
The New Zealand obese mouse (NZO/Hl) is characterised by hereditary obesity and type-2 diabetes, including insulin resistance, hyperinsulinaemia, and glucose intolerance. In other diabetic models, it has been revealed that the proper functioning of the glucose transporter isoform 2 (GLUT2) is essential for adequate secretion of insulin. The aim of this study was to compare the distribution of islet cells and GLUT2, as well as the expression of GLUT2-mRNA, in the pancreas of NZO mice and metabolically unimpaired NMRI (Naval Medical Research Institute) mice. Pancreas tissue was obtained from different stages of development. For molecular determination of the expression level of GLUT2-mRNA, total-RNA was extracted from the pancreas and analysed by quantitative real-time RT-PCR. All investigated NZO mice displayed increased weight, elevated hyperinsulinaemia, and slightly enhanced blood glucose levels compared with the NMRI control mice. By means of immunofluorescence microscopy drastically reduced insulin levels were detected, which might be compensated by the observed islet cell hyperplasia and hypertrophy. Furthermore, the normally peripheral localisation of the alpha-cells within islets was disturbed. By contrast, there were no changes in somatostatin cell distribution. However, considerable differences appeared with regard to GLUT2: whereas the beta-cells of NMRI mice showed dense immunostaining of the GLUT2 transporter on the cell surface, in all age groups of NZO mice, GLUT2 on the plasma membranes was reduced and dispersed in the cytoplasm. These findings agree with the molecular biological results, which displayed decreased mRNA-expression of GLUT2. In summary, the observed alteration of islet morphology and of GLUT2 expression in diabetic mice complements our previous results from a superfusion protocol and further clarifies the mechanisms of diabetogenesis in NZO mice. 相似文献
105.
Hideki Kawaguchi Kazuko Masuo Tomohiro Katsuya Ken Sugimoto Hiromi Rakugi Toshio Ogihara Michael L Tuck 《Hypertension research》2006,29(12):951-959
High blood pressure (BP) is a major determinant of cardiovascular events in obesity. The beta2- and beta3-adrenoceptor polymorphisms are associated with obesity and hypertension. In the present study, we examine the relationships of beta2- and beta3-adrenoceptor polymorphisms with further weight gain-induced BP elevation in obese subjects. Changes in BP, body weight, total body fat-mass, waist-to-hip ratio, plasma norepinephrine (NE) and leptin levels, and beta2(Arg16Gly)- and beta3(Trp64Arg)-adrenoceptor polymorphisms were measured periodically over a 5-year period in 55 entry obese (body mass index [BMI]> or =25.0 kg/m(2)) normotensive (BP<140/90 mmHg) men. BP elevation and weight gain were defined as > or =10% increases from entry levels over 5 years in mean BP or BMI. Obese subjects with weight gain, BP elevation or weight gain-induced BP elevation had higher frequencies of the Gly16 allele of Arg16GIy and Arg64 allele of Trp64Arg. Subjects carrying the Gly16 or Arg64 alleles had significantly greater total fat-mass and waist-to-hip ratio at entry and over a 5-year period compared to the subjects who did not carry these polymorphisms. Subjects carrying the Gly16 allele had similar levels of plasma NE, higher levels of plasma leptin and a lower slope of the regression lines between plasma leptin and NE levels. Those carrying the Arg64 allele had higher plasma NE levels at entry and over a 5-year period compared to the subjects without the Arg64 allele, but plasma leptin levels and slopes were similar. The findings demonstrate that the Arg64 allele of the beta3-adrenoceptor polymorphisms relates to weight gain-induced BP elevation accompanying high plasma NE (heightened sympathetic activity) in obese men. The Gly16 allele of the beta2-adrenoceptor polymorphisms links to weight gain-induced BP elevation associated with leptin resistance. beta2- and beta3-adrenoceptor polymorphisms could predict the future BP elevation and further weight gain-induced BP elevation in originally obese subjects. 相似文献
106.
107.
108.
109.
110.
J. F. Trotter J. Campsen T. Bak M. Wachs L. Forman G. Everson I. Kam 《American journal of transplantation》2006,6(8):1882-1889
The purpose of this study is to determine the role of liver biopsy and outcome of patients undergoing donor evaluation for adult-to-adult right hepatic lobe living donor liver transplantation (LDLT). Records of patients presenting for a comprehensive donor evaluation between 1997 and February 2005 were reviewed. Liver biopsy was performed only in patients with risk factors for abnormal histology. Two hundred and sixty patients underwent a comprehensive donor evaluation and 116 of 260 (45%) were suitable for donation, 14 of 260 (5.4%) did not complete evaluation and 130 of 260 (50%) were rejected. Four patients underwent unsuccessful hepatectomy surgery due to discovery of intraoperative abnormalities. Between 1997 and 2001, the acceptance rate of donor candidates (63%) was higher than 2002-2005 (36%), p < 0.0001. Sixty-six of the 150 eligible patients (44%) fulfilled criteria for liver biopsy and 28 of 66 (42%) had an abnormal finding. Less than half of the patients undergoing donor evaluation were suitable donors and the donor acceptance rate has declined over time. A large proportion of the patients undergoing liver biopsy have abnormal findings. Our evaluation process failed to identify 4 of 103 who had aborted donor surgeries. 相似文献